EcoDrugPlus

V-Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A

Ensembl ID : ENSOMYG00000009183
Gene Symbol: RELA
1 Cross references
194 Possible Orthologues:

V-Src Avian Sarcoma (Schmidt-Ruppin A-2) Viral Oncogene Homolog

Ensembl ID : ENSOMYG00000008029
Gene Symbol: SRC
2 Cross references
191 Possible Orthologues:

Vascular Endothelial Growth Factor Ab

Ensembl ID : ENSOMYG00000020744
Gene Symbol: VEGFAB
1 Cross references
195 Possible Orthologues:

Vascular Endothelial Growth Factor Ab

Ensembl ID : ENSOMYG00000017345
Gene Symbol: VEGFAB
1 Cross references
195 Possible Orthologues:

Vascular Endothelial Growth Factor Precursor

Ensembl ID : ENSOMYG00000010298
Gene Symbol: VEGF
3 Cross references
175 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSOMYG00000074973
Gene Symbol: XDH
1 Cross references
210 Possible Orthologues:

Ensembl ID : ENSOMYG00000008173
Gene Symbol: -
Cross references: -
169 Possible Orthologues:

Ensembl ID : ENSOMYG00000008139
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSOMYG00000008122
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSOMYG00000013537
Gene Symbol: RPL27
1 Cross references
363 Possible Orthologues:

Ensembl ID : ENSOMYG00000013660
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSOMYG00000008082
Gene Symbol: -
Cross references: -
208 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).